netFormulary NHS
North East and North Cumbria
ICS Formulary
 Search
 Results

Looking for Ritonavir found 8 matches
Open monograph to display formulary status BNF Category
  Lopinavir and Ritonavir  (Kaletra®) Infections - Combination Products - 05.03.01
  Nirmatrelvir and Ritonavir  (Paxlovid®) Infections - COVID-19 therapeutics - 05.03.06
  Ritonavir Infections - Protease inhibitors - 05.03.01
  Restricted Drug Remdesivir  (Veklury®) Infections - COVID-19 therapeutics - 05.03.06
 


Linkslink in drug section Link to Drug Section link in subsection Link to document
link in drug section MHRA Drug Safety Update (November 2023) : Nirmatrelvir, ritonavir (Paxlovid▼): be alert to the risk of drug interactions with ritonavir (05.03.06)
link in drug section NICE TA878: Casirivimab plus imdevimab, nirmatrelvir plus ritonavir, sotrovimab and tocilizumab for treating COVID-19 (05.03.06)
link in drug section NICE TA878: Casirivimab plus imdevimab, nirmatrelvir plus ritonavir, sotrovimab and tocilizumab for treating COVID-19 (05.03.06)
link in drug section NICE TA878: Nirmatrelvir plus ritonavir, sotrovimab and tocilizumab for treating COVID-19 (05.03.06)


 
netFormulary